Early results from the first US trial to treat cancer patients using their own immune cells edited with CRISPR/Cas9 technology have shown the procedure to be safe, researchers will report.
Researchers from the Abramson Cancer Cen...
2 months ago
A pre-clinical study has suggested that antibiotics can be used to overcome resistance to a promising drug for acute myeloid leukaemia (AML).
Despite venetoclax being hailed as a successful treatment for some people with AML, a s...
2 months ago